MedTrace Logo

L-Arginine in the Treatment of Peripheral Arterial Disease

NCT00284076 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-03-05

No results posted yet for this study

Summary

To assess the effects of L-arginine upon functional status (treadmill exercise testing; quality of life) and limb blood (by mercury strain gauge plethysmography) in peripheral arterial disease.

Conditions

Interventions

DRUG

L-arginine

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Stanford University

    lead OTHER

Principal Investigators

  • John Cooke · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-02-29
Primary Completion
2006-07-31
Completion
2006-07-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00284076 on ClinicalTrials.gov